BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 539973 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29) OTTJIRVZJJGFTK-UHFFFAOYSA-N 50181508 CHEMBL3818083::US10023539, Example 4.2 N-lysine methyltransferase SMYD2 Human 28.2 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50181508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50181508&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397061 104066346 CHEMBL3818083 ZINC13680295 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539974 CCN(C1CN(N=C1c1ccc(Cl)cc1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H21ClF2N6O3/c1-2-30(19(33)12-32)18-11-31(29-20(18)14-6-8-15(23)9-7-14)22(27-13-26)28-16-4-3-5-17(10-16)34-21(24)25/h3-10,18,21,32H,2,11-12H2,1H3,(H,27,28) GZPIECMFJJLDAB-UHFFFAOYSA-N 50181512 CHEMBL3819277::US10023539, Example WO 2006/072350 Example 67 N-lysine methyltransferase SMYD2 Human 548 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50181512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50181512&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 127051546 104066350 CHEMBL3819277 ZINC13680325 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539975 C[C@H](O)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C21H18Cl2F2N6O3/c1-11(32)19(33)29-17-9-31(30-18(17)12-5-6-15(22)16(23)7-12)21(27-10-26)28-13-3-2-4-14(8-13)34-20(24)25/h2-8,11,17,20,32H,9H2,1H3,(H,27,28)(H,29,33)/t11-,17?/m0/s1 UMPBDSJXAXDDOB-PIJUOJQZSA-N 283130 (2S)¿N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-2-hydroxypropanamide::US10023539, Example 1 N-lysine methyltransferase SMYD2 Human 518 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283130&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397086 378164482 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539976 CN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C21H18Cl2F2N6O3/c1-30(18(33)10-32)17-9-31(29-19(17)12-5-6-15(22)16(23)7-12)21(27-11-26)28-13-3-2-4-14(8-13)34-20(24)25/h2-8,17,20,32H,9-10H2,1H3,(H,27,28) HNQIUGWQCAEIMV-UHFFFAOYSA-N 283131 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-2-hydroxy-N-methylacetamide::US10023539, Example 2 N-lysine methyltransferase SMYD2 Human 83.3 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283131&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397034 378164483 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539977 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CN InChI=1S/C22H21Cl2F2N7O2/c1-2-32(19(34)10-27)18-11-33(31-20(18)13-6-7-16(23)17(24)8-13)22(29-12-28)30-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21H,2,10-11,27H2,1H3,(H,29,30) NYIWCWBYWZAIAY-UHFFFAOYSA-N 283132 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethylglycinamide::US10023539, Example 3 N-lysine methyltransferase SMYD2 Human 15.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283132&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121405333 378164484 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539979 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29) OTTJIRVZJJGFTK-UHFFFAOYSA-N 283133 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 4 N-lysine methyltransferase SMYD2 Human 82.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283133&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397061 378164485 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539981 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29) OTTJIRVZJJGFTK-UHFFFAOYSA-N 50181508 CHEMBL3818083::US10023539, Example 4.2 N-lysine methyltransferase SMYD2 Human 28.2 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50181508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50181508&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397061 104066346 CHEMBL3818083 ZINC13680295 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539983 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29) OTTJIRVZJJGFTK-UHFFFAOYSA-N 50181508 CHEMBL3818083::US10023539, Example 4.2 N-lysine methyltransferase SMYD2 Human 1320 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50181508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50181508&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397061 104066346 CHEMBL3818083 ZINC13680295 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539985 CC(C)(O)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C22H20Cl2F2N6O3/c1-22(2,34)19(33)30-17-10-32(31-18(17)12-6-7-15(23)16(24)8-12)21(28-11-27)29-13-4-3-5-14(9-13)35-20(25)26/h3-9,17,20,34H,10H2,1-2H3,(H,28,29)(H,30,33) NXEYFTZEYSZYHX-UHFFFAOYSA-N 283135 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-2-hydroxy-2-methylpropanamide::US10023539, Example 5 N-lysine methyltransferase SMYD2 Human 785 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283135&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397101 378164487 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539987 CC(C)(O)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C22H20Cl2F2N6O3/c1-22(2,34)19(33)30-17-10-32(31-18(17)12-6-7-15(23)16(24)8-12)21(28-11-27)29-13-4-3-5-14(9-13)35-20(25)26/h3-9,17,20,34H,10H2,1-2H3,(H,28,29)(H,30,33) NXEYFTZEYSZYHX-UHFFFAOYSA-N 283136 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-2-hydroxy-2-methylpropanamide Isomer 1::US10023539, Example 5.1::US10023539, Example 5.2 N-lysine methyltransferase SMYD2 Human >20000 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283136&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397101 378164488 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539988 CC(C)(O)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C22H20Cl2F2N6O3/c1-22(2,34)19(33)30-17-10-32(31-18(17)12-6-7-15(23)16(24)8-12)21(28-11-27)29-13-4-3-5-14(9-13)35-20(25)26/h3-9,17,20,34H,10H2,1-2H3,(H,28,29)(H,30,33) NXEYFTZEYSZYHX-UHFFFAOYSA-N 283136 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-2-hydroxy-2-methylpropanamide Isomer 1::US10023539, Example 5.1::US10023539, Example 5.2 N-lysine methyltransferase SMYD2 Human 296 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283136&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397101 378164488 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539989 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CCN InChI=1S/C23H23Cl2F2N7O2/c1-2-33(20(35)8-9-28)19-12-34(32-21(19)14-6-7-17(24)18(25)10-14)23(30-13-29)31-15-4-3-5-16(11-15)36-22(26)27/h3-7,10-11,19,22H,2,8-9,12,28H2,1H3,(H,30,31) BNGMDZHWVUWQIF-UHFFFAOYSA-N 283138 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-beta-alaninamide::US10023539, Example 6 N-lysine methyltransferase SMYD2 Human 286 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283138&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397022 378164489 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539990 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@@H](C)N InChI=1S/C23H23Cl2F2N7O2/c1-3-33(21(35)13(2)29)19-11-34(32-20(19)14-7-8-17(24)18(25)9-14)23(30-12-28)31-15-5-4-6-16(10-15)36-22(26)27/h4-10,13,19,22H,3,11,29H2,1-2H3,(H,30,31)/t13-,19?/m1/s1 DVPSDCLFZOUIOA-BSOCMFCZSA-N 283139 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-D-alaninamide Isomer 1::US10023539, Example 7.1::US10023539, Example 7.2 N-lysine methyltransferase SMYD2 Human 13.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283139&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397063 378164490 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539992 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@@H](C)N InChI=1S/C23H23Cl2F2N7O2/c1-3-33(21(35)13(2)29)19-11-34(32-20(19)14-7-8-17(24)18(25)9-14)23(30-12-28)31-15-5-4-6-16(10-15)36-22(26)27/h4-10,13,19,22H,3,11,29H2,1-2H3,(H,30,31)/t13-,19?/m1/s1 DVPSDCLFZOUIOA-BSOCMFCZSA-N 283139 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-D-alaninamide Isomer 1::US10023539, Example 7.1::US10023539, Example 7.2 N-lysine methyltransferase SMYD2 Human 1050 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283139&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397063 378164490 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539993 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@H](C)O InChI=1S/C23H22Cl2F2N6O3/c1-3-32(21(35)13(2)34)19-11-33(31-20(19)14-7-8-17(24)18(25)9-14)23(29-12-28)30-15-5-4-6-16(10-15)36-22(26)27/h4-10,13,19,22,34H,3,11H2,1-2H3,(H,29,30)/t13-,19?/m0/s1 PTAMOQNBPVQUNA-YTJLLHSVSA-N 283142 (2S)—N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxypropanamide (1:1 Mixture of Diastereomers)::US10023539, Example 8 N-lysine methyltransferase SMYD2 Human 90.1 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283142&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397095 378164492 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539994 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@@H](C)O InChI=1S/C23H22Cl2F2N6O3/c1-3-32(21(35)13(2)34)19-11-33(31-20(19)14-7-8-17(24)18(25)9-14)23(29-12-28)30-15-5-4-6-16(10-15)36-22(26)27/h4-10,13,19,22,34H,3,11H2,1-2H3,(H,29,30)/t13-,19?/m1/s1 PTAMOQNBPVQUNA-BSOCMFCZSA-N 283143 (2R)—N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxypropanamide (1:1 Mixture of Diastereomers)::US10023539, Example 9 N-lysine methyltransferase SMYD2 Human 13.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283143&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397035 378164493 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539996 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CCCN InChI=1S/C24H25Cl2F2N7O2/c1-2-34(21(36)7-4-10-29)20-13-35(33-22(20)15-8-9-18(25)19(26)11-15)24(31-14-30)32-16-5-3-6-17(12-16)37-23(27)28/h3,5-6,8-9,11-12,20,23H,2,4,7,10,13,29H2,1H3,(H,31,32) DRABPHUFBFTADU-UHFFFAOYSA-N 283144 Rac-4-amino-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethylbutanamide::US10023539, Example 10::US10023539, Example 10.1::US10023539, Example 10.2 N-lysine methyltransferase SMYD2 Human 466 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283144&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397053 378164494 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539998 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CCCN InChI=1S/C24H25Cl2F2N7O2/c1-2-34(21(36)7-4-10-29)20-13-35(33-22(20)15-8-9-18(25)19(26)11-15)24(31-14-30)32-16-5-3-6-17(12-16)37-23(27)28/h3,5-6,8-9,11-12,20,23H,2,4,7,10,13,29H2,1H3,(H,31,32) DRABPHUFBFTADU-UHFFFAOYSA-N 283144 Rac-4-amino-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethylbutanamide::US10023539, Example 10::US10023539, Example 10.1::US10023539, Example 10.2 N-lysine methyltransferase SMYD2 Human 199 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283144&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397053 378164494 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 539999 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CCCN InChI=1S/C24H25Cl2F2N7O2/c1-2-34(21(36)7-4-10-29)20-13-35(33-22(20)15-8-9-18(25)19(26)11-15)24(31-14-30)32-16-5-3-6-17(12-16)37-23(27)28/h3,5-6,8-9,11-12,20,23H,2,4,7,10,13,29H2,1H3,(H,31,32) DRABPHUFBFTADU-UHFFFAOYSA-N 283144 Rac-4-amino-N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethylbutanamide::US10023539, Example 10::US10023539, Example 10.1::US10023539, Example 10.2 N-lysine methyltransferase SMYD2 Human 3830 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283144&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397053 378164494 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540000 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1ccc(Cl)c(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl3F2N6O3/c1-2-32(19(35)10-34)17-9-33(31-20(17)12-3-5-14(23)16(25)7-12)22(29-11-28)30-13-4-6-15(24)18(8-13)36-21(26)27/h3-8,17,21,34H,2,9-10H2,1H3,(H,29,30) GAPYHYWZUSFPBS-UHFFFAOYSA-N 283148 Rac-N-[1-{N-[4-chloro-3-(difluoromethoxy)phenyl]-N′-cyanocarbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 11 N-lysine methyltransferase SMYD2 Human 144 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283148&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397104 378164496 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540002 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1ccc(Cl)c(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl3F2N6O3/c1-2-32(19(35)10-34)17-9-33(31-20(17)12-3-5-14(23)16(25)7-12)22(29-11-28)30-13-4-6-15(24)18(8-13)36-21(26)27/h3-8,17,21,34H,2,9-10H2,1H3,(H,29,30) GAPYHYWZUSFPBS-UHFFFAOYSA-N 283150 N-[1-{N-[4-chloro-3-(difluoromethoxy)phenyl]-N′-cyanocarbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 11.1::US10023539, Example 11.2 N-lysine methyltransferase SMYD2 Human 44.1 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283150&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397104 378164498 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540003 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1ccc(Cl)c(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl3F2N6O3/c1-2-32(19(35)10-34)17-9-33(31-20(17)12-3-5-14(23)16(25)7-12)22(29-11-28)30-13-4-6-15(24)18(8-13)36-21(26)27/h3-8,17,21,34H,2,9-10H2,1H3,(H,29,30) GAPYHYWZUSFPBS-UHFFFAOYSA-N 283150 N-[1-{N-[4-chloro-3-(difluoromethoxy)phenyl]-N′-cyanocarbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 11.1::US10023539, Example 11.2 N-lysine methyltransferase SMYD2 Human 2980 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283150&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397104 378164498 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540004 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1F)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(18(36)10-35)16-9-34(32-20(16)12-6-7-13(23)14(24)8-12)21(30-11-29)31-15-4-3-5-17(19(15)25)37-22(26,27)28/h3-8,16,35H,2,9-10H2,1H3,(H,30,31) MMTFZCJTRSDCKE-UHFFFAOYSA-N 283154 Rac-N-[1-{N′-cyano-N-[2-fluoro-3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 12 N-lysine methyltransferase SMYD2 Human 138 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283154&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397106 378164501 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540005 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1F)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(18(36)10-35)16-9-34(32-20(16)12-6-7-13(23)14(24)8-12)21(30-11-29)31-15-4-3-5-17(19(15)25)37-22(26,27)28/h3-8,16,35H,2,9-10H2,1H3,(H,30,31) MMTFZCJTRSDCKE-UHFFFAOYSA-N 283156 N-[1-{N′-cyano-N-[2-fluoro-3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 12.1::US10023539, Example 12.2 N-lysine methyltransferase SMYD2 Human 2660 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283156&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397106 378164503 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540006 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1F)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(18(36)10-35)16-9-34(32-20(16)12-6-7-13(23)14(24)8-12)21(30-11-29)31-15-4-3-5-17(19(15)25)37-22(26,27)28/h3-8,16,35H,2,9-10H2,1H3,(H,30,31) MMTFZCJTRSDCKE-UHFFFAOYSA-N 283156 N-[1-{N′-cyano-N-[2-fluoro-3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 12.1::US10023539, Example 12.2 N-lysine methyltransferase SMYD2 Human 54.1 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283156&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397106 378164503 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540007 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)11-34)18-10-33(31-20(18)13-6-7-16(23)17(24)8-13)21(29-12-28)30-14-4-3-5-15(9-14)36-22(25,26)27/h3-9,18,34H,2,10-11H2,1H3,(H,29,30) IZRPQPPVUDTQGE-UHFFFAOYSA-N 283158 Rac-N-[1-{N′-cyano-N-[3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 13 N-lysine methyltransferase SMYD2 Human 86.7 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283158&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397040 378164504 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540009 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)11-34)18-10-33(31-20(18)13-6-7-16(23)17(24)8-13)21(29-12-28)30-14-4-3-5-15(9-14)36-22(25,26)27/h3-9,18,34H,2,10-11H2,1H3,(H,29,30) IZRPQPPVUDTQGE-UHFFFAOYSA-N 283158 Rac-N-[1-{N′-cyano-N-[3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 13 N-lysine methyltransferase SMYD2 Human 254 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283158&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397040 378164504 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540010 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)11-34)18-10-33(31-20(18)13-6-7-16(23)17(24)8-13)21(29-12-28)30-14-4-3-5-15(9-14)36-22(25,26)27/h3-9,18,34H,2,10-11H2,1H3,(H,29,30) IZRPQPPVUDTQGE-UHFFFAOYSA-N 283159 N-[1-{N′-cyano-N-[3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 13.1::US10023539, Example 13.2 N-lysine methyltransferase SMYD2 Human 4610 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283159&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397040 378164505 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540011 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)11-34)18-10-33(31-20(18)13-6-7-16(23)17(24)8-13)21(29-12-28)30-14-4-3-5-15(9-14)36-22(25,26)27/h3-9,18,34H,2,10-11H2,1H3,(H,29,30) IZRPQPPVUDTQGE-UHFFFAOYSA-N 283159 N-[1-{N′-cyano-N-[3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 13.1::US10023539, Example 13.2 N-lysine methyltransferase SMYD2 Human 50.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283159&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397040 378164505 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540013 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1ccc(F)c(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(19(36)10-35)17-9-34(32-20(17)12-3-5-14(23)15(24)7-12)21(30-11-29)31-13-4-6-16(25)18(8-13)37-22(26,27)28/h3-8,17,35H,2,9-10H2,1H3,(H,30,31) DHDANOYEPZIITC-UHFFFAOYSA-N 283161 Rac-N-[1-{N′-cyano-N-[4-fluoro-3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 14 N-lysine methyltransferase SMYD2 Human 147 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283161&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397078 378164506 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540014 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC)c1)=N/C#N)C(=O)CO InChI=1S/C22H22Cl2N6O3/c1-3-29(20(32)12-31)19-11-30(28-21(19)14-7-8-17(23)18(24)9-14)22(26-13-25)27-15-5-4-6-16(10-15)33-2/h4-10,19,31H,3,11-12H2,1-2H3,(H,26,27) RSRIZCHLFZZEQL-UHFFFAOYSA-N 283162 Rac-N-{1-[N′-cyano-N-(3-methoxyphenyl)carbamimidoyl]-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl}-N-ethyl-2-hydroxyacetamide::US10023539, Example 15 N-lysine methyltransferase SMYD2 Human 121 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283162&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397057 378164507 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540015 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC)c1)=N/C#N)C(=O)CO InChI=1S/C22H22Cl2N6O3/c1-3-29(20(32)12-31)19-11-30(28-21(19)14-7-8-17(23)18(24)9-14)22(26-13-25)27-15-5-4-6-16(10-15)33-2/h4-10,19,31H,3,11-12H2,1-2H3,(H,26,27) RSRIZCHLFZZEQL-UHFFFAOYSA-N 283163 N-{1-[N′-cyano-N-(3-methoxyphenyl)carbamimidoyl]-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl}-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 15.1::US10023539, Example 15.2 N-lysine methyltransferase SMYD2 Human 17600 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283163&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397057 378164508 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540016 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC)c1)=N/C#N)C(=O)CO InChI=1S/C22H22Cl2N6O3/c1-3-29(20(32)12-31)19-11-30(28-21(19)14-7-8-17(23)18(24)9-14)22(26-13-25)27-15-5-4-6-16(10-15)33-2/h4-10,19,31H,3,11-12H2,1-2H3,(H,26,27) RSRIZCHLFZZEQL-UHFFFAOYSA-N 283163 N-{1-[N′-cyano-N-(3-methoxyphenyl)carbamimidoyl]-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl}-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 15.1::US10023539, Example 15.2 N-lysine methyltransferase SMYD2 Human 71.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283163&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397057 378164508 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540018 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OCCN(C)C)c1)=N/C#N)C(=O)CO InChI=1S/C25H29Cl2N7O3/c1-4-33(23(36)15-35)22-14-34(31-24(22)17-8-9-20(26)21(27)12-17)25(29-16-28)30-18-6-5-7-19(13-18)37-11-10-32(2)3/h5-9,12-13,22,35H,4,10-11,14-15H2,1-3H3,(H,29,30) UCPRLOSRLQDYHR-UHFFFAOYSA-N 283165 Rac-N-[1-(N′-cyano-N-{3-[2-(dimethylamino)ethoxy]phenyl}carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 16 N-lysine methyltransferase SMYD2 Human 358 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283165&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397089 378164509 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540019 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OCCN(C)C)c1)=N/C#N)C(=O)CO InChI=1S/C25H29Cl2N7O3/c1-4-33(23(36)15-35)22-14-34(31-24(22)17-8-9-20(26)21(27)12-17)25(29-16-28)30-18-6-5-7-19(13-18)37-11-10-32(2)3/h5-9,12-13,22,35H,4,10-11,14-15H2,1-3H3,(H,29,30) UCPRLOSRLQDYHR-UHFFFAOYSA-N 283166 N-[1-(N′-cyano-N-{3-[2-(dimethylamino)ethoxy]phenyl}carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 16.1::US10023539, Example 16.2 N-lysine methyltransferase SMYD2 Human 4790 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283166&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397089 378164510 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540020 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OCCN(C)C)c1)=N/C#N)C(=O)CO InChI=1S/C25H29Cl2N7O3/c1-4-33(23(36)15-35)22-14-34(31-24(22)17-8-9-20(26)21(27)12-17)25(29-16-28)30-18-6-5-7-19(13-18)37-11-10-32(2)3/h5-9,12-13,22,35H,4,10-11,14-15H2,1-3H3,(H,29,30) UCPRLOSRLQDYHR-UHFFFAOYSA-N 283166 N-[1-(N′-cyano-N-{3-[2-(dimethylamino)ethoxy]phenyl}carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 16.1::US10023539, Example 16.2 N-lysine methyltransferase SMYD2 Human 159 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283166&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397089 378164510 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540022 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OCCN(C)C)c1)=N/C#N)C(=O)CN InChI=1S/C25H30Cl2N8O2/c1-4-34(23(36)14-28)22-15-35(32-24(22)17-8-9-20(26)21(27)12-17)25(30-16-29)31-18-6-5-7-19(13-18)37-11-10-33(2)3/h5-9,12-13,22H,4,10-11,14-15,28H2,1-3H3,(H,30,31) OYIQHUSFOOWCIX-UHFFFAOYSA-N 283168 Rac-N-[1-(N′-cyano-N-{3-[2-(dimethylamino)ethoxy]phenyl}carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethylglycinamide::US10023539, Example 17 N-lysine methyltransferase SMYD2 Human 59.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283168&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397073 378164511 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540023 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(OC(F)F)ccc1OC)=N/C#N)C(=O)CO InChI=1S/C23H22Cl2F2N6O4/c1-3-32(20(35)11-34)18-10-33(31-21(18)13-4-6-15(24)16(25)8-13)23(29-12-28)30-17-9-14(37-22(26)27)5-7-19(17)36-2/h4-9,18,22,34H,3,10-11H2,1-2H3,(H,29,30) QQPHPVYMZKZLSZ-UHFFFAOYSA-N 283169 Rac-N-[1-{N′-cyano-N-[5-(difluoromethoxy)-2-methoxyphenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 18 N-lysine methyltransferase SMYD2 Human 12.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283169&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397090 378164512 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540025 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(OC(F)F)ccc1OC)=N/C#N)C(=O)CO InChI=1S/C23H22Cl2F2N6O4/c1-3-32(20(35)11-34)18-10-33(31-21(18)13-4-6-15(24)16(25)8-13)23(29-12-28)30-17-9-14(37-22(26)27)5-7-19(17)36-2/h4-9,18,22,34H,3,10-11H2,1-2H3,(H,29,30) QQPHPVYMZKZLSZ-UHFFFAOYSA-N 283170 N-[1-{N′-cyano-N-[5-(difluoromethoxy)-2-methoxyphenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 18.1::US10023539, Example 18.2 N-lysine methyltransferase SMYD2 Human >20000 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283170&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397090 378164513 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540026 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(OC(F)F)ccc1OC)=N/C#N)C(=O)CO InChI=1S/C23H22Cl2F2N6O4/c1-3-32(20(35)11-34)18-10-33(31-21(18)13-4-6-15(24)16(25)8-13)23(29-12-28)30-17-9-14(37-22(26)27)5-7-19(17)36-2/h4-9,18,22,34H,3,10-11H2,1-2H3,(H,29,30) QQPHPVYMZKZLSZ-UHFFFAOYSA-N 283170 N-[1-{N′-cyano-N-[5-(difluoromethoxy)-2-methoxyphenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 18.1::US10023539, Example 18.2 N-lysine methyltransferase SMYD2 Human 30.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283170&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397090 378164513 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540028 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OC)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O3/c1-3-33(20(36)11-35)18-10-34(32-21(18)13-4-6-15(24)16(25)8-13)22(30-12-29)31-17-9-14(23(26,27)28)5-7-19(17)37-2/h4-9,18,35H,3,10-11H2,1-2H3,(H,30,31) WTIWMLACYVVULJ-UHFFFAOYSA-N 283172 Rac-N-[1-{N′-cyano-N-[2-methoxy-5-(trifluoromethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 19 N-lysine methyltransferase SMYD2 Human 9.98 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283172&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397098 378164514 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540030 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OC)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O3/c1-3-33(20(36)11-35)18-10-34(32-21(18)13-4-6-15(24)16(25)8-13)22(30-12-29)31-17-9-14(23(26,27)28)5-7-19(17)37-2/h4-9,18,35H,3,10-11H2,1-2H3,(H,30,31) WTIWMLACYVVULJ-UHFFFAOYSA-N 283173 N-[1-{N′-cyano-N-[2-methoxy-5-(trifluoromethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 19.1::US10023539, Example 19.2 N-lysine methyltransferase SMYD2 Human 768 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283173&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397098 378164515 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540031 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OC)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O3/c1-3-33(20(36)11-35)18-10-34(32-21(18)13-4-6-15(24)16(25)8-13)22(30-12-29)31-17-9-14(23(26,27)28)5-7-19(17)37-2/h4-9,18,35H,3,10-11H2,1-2H3,(H,30,31) WTIWMLACYVVULJ-UHFFFAOYSA-N 283173 N-[1-{N′-cyano-N-[2-methoxy-5-(trifluoromethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 19.1::US10023539, Example 19.2 N-lysine methyltransferase SMYD2 Human 6.65 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283173&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397098 378164515 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540033 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)n1)=N/C#N)C(=O)CO InChI=1S/C21H19Cl2F2N7O3/c1-2-31(18(34)10-33)15-9-32(30-19(15)12-6-7-13(22)14(23)8-12)21(27-11-26)29-16-4-3-5-17(28-16)35-20(24)25/h3-8,15,20,33H,2,9-10H2,1H3,(H,27,28,29) DPHXTJJOYFZBPD-UHFFFAOYSA-N 283175 Rac-N-[1-{N′-cyano-N-[6-(difluoromethoxy)pyridin-2-yl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 20 N-lysine methyltransferase SMYD2 Human 247 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283175&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397028 378164516 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540035 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)n1)=N/C#N)C(=O)CO InChI=1S/C21H19Cl2F2N7O3/c1-2-31(18(34)10-33)15-9-32(30-19(15)12-6-7-13(22)14(23)8-12)21(27-11-26)29-16-4-3-5-17(28-16)35-20(24)25/h3-8,15,20,33H,2,9-10H2,1H3,(H,27,28,29) DPHXTJJOYFZBPD-UHFFFAOYSA-N 283176 N-[1-{N′-cyano-N-[6-(difluoromethoxy)pyridin-2-yl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 20.1::US10023539, Example 20.2 N-lysine methyltransferase SMYD2 Human 17400 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283176&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397028 378164517 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540036 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)n1)=N/C#N)C(=O)CO InChI=1S/C21H19Cl2F2N7O3/c1-2-31(18(34)10-33)15-9-32(30-19(15)12-6-7-13(22)14(23)8-12)21(27-11-26)29-16-4-3-5-17(28-16)35-20(24)25/h3-8,15,20,33H,2,9-10H2,1H3,(H,27,28,29) DPHXTJJOYFZBPD-UHFFFAOYSA-N 283176 N-[1-{N′-cyano-N-[6-(difluoromethoxy)pyridin-2-yl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 20.1::US10023539, Example 20.2 N-lysine methyltransferase SMYD2 Human 119 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283176&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397028 378164517 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540037 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(CC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O2/c1-2-33(20(36)12-35)19-11-34(32-21(19)15-6-7-17(24)18(25)9-15)22(30-13-29)31-16-5-3-4-14(8-16)10-23(26,27)28/h3-9,19,35H,2,10-12H2,1H3,(H,30,31) HFGPNWMIXULCHO-UHFFFAOYSA-N 283178 Rac-N-[1-{N′-cyano-N-[3-(2,2,2-trifluoroethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 21 N-lysine methyltransferase SMYD2 Human 1070 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283178&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397036 378164518 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540038 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(CC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O2/c1-2-33(20(36)12-35)19-11-34(32-21(19)15-6-7-17(24)18(25)9-15)22(30-13-29)31-16-5-3-4-14(8-16)10-23(26,27)28/h3-9,19,35H,2,10-12H2,1H3,(H,30,31) HFGPNWMIXULCHO-UHFFFAOYSA-N 283179 N-[1-{N′-cyano-N-[3-(2,2,2-trifluoroethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 21.1::US10023539, Example 21.2 N-lysine methyltransferase SMYD2 Human 53.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283179&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397036 378164519 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540039 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(CC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O2/c1-2-33(20(36)12-35)19-11-34(32-21(19)15-6-7-17(24)18(25)9-15)22(30-13-29)31-16-5-3-4-14(8-16)10-23(26,27)28/h3-9,19,35H,2,10-12H2,1H3,(H,30,31) HFGPNWMIXULCHO-UHFFFAOYSA-N 283179 N-[1-{N′-cyano-N-[3-(2,2,2-trifluoroethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 21.1::US10023539, Example 21.2 N-lysine methyltransferase SMYD2 Human 763 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283179&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397036 378164519 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540040 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1ccc(F)c(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)10-34)17-9-33(31-20(17)12-3-5-14(23)15(24)7-12)22(29-11-28)30-13-4-6-16(25)18(8-13)36-21(26)27/h3-8,17,21,34H,2,9-10H2,1H3,(H,29,30) NZMJLHQORQSELK-UHFFFAOYSA-N 283181 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)-4-fluorophenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 22 N-lysine methyltransferase SMYD2 Human 64.8 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283181&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397079 378164520 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540041 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1F)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(18(35)10-34)16-9-33(31-20(16)12-6-7-13(23)14(24)8-12)22(29-11-28)30-15-4-3-5-17(19(15)25)36-21(26)27/h3-8,16,21,34H,2,9-10H2,1H3,(H,29,30) RLYSYHBVRZJOPN-UHFFFAOYSA-N 283182 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)-2-fluorophenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 23 N-lysine methyltransferase SMYD2 Human 67.4 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283182&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397088 378164521 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540042 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(F)cc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)10-34)18-9-33(31-20(18)12-3-4-16(23)17(24)5-12)22(29-11-28)30-14-6-13(25)7-15(8-14)36-21(26)27/h3-8,18,21,34H,2,9-10H2,1H3,(H,29,30) GOXPTBFRMOWJPX-UHFFFAOYSA-N 283183 Rac-N-[1-{N′-cyano-N-[3-(difluoromethoxy)-5-fluorophenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 24 N-lysine methyltransferase SMYD2 Human 63.1 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283183&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397050 378164522 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540043 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(F)cc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)10-34)18-9-33(31-20(18)12-3-4-16(23)17(24)5-12)22(29-11-28)30-14-6-13(25)7-15(8-14)36-21(26)27/h3-8,18,21,34H,2,9-10H2,1H3,(H,29,30) GOXPTBFRMOWJPX-UHFFFAOYSA-N 283184 N-[1-{N′-cyano-N-[3-(difluoromethoxy)-5-fluorophenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 24.1::US10023539, Example 24.2 N-lysine methyltransferase SMYD2 Human 2510 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283184&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397050 378164523 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540044 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(F)cc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19Cl2F3N6O3/c1-2-32(19(35)10-34)18-9-33(31-20(18)12-3-4-16(23)17(24)5-12)22(29-11-28)30-14-6-13(25)7-15(8-14)36-21(26)27/h3-8,18,21,34H,2,9-10H2,1H3,(H,29,30) GOXPTBFRMOWJPX-UHFFFAOYSA-N 283184 N-[1-{N′-cyano-N-[3-(difluoromethoxy)-5-fluorophenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 24.1::US10023539, Example 24.2 N-lysine methyltransferase SMYD2 Human 19.2 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283184&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397050 378164523 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540045 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(F)cc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(19(36)10-35)18-9-34(32-20(18)12-3-4-16(23)17(24)5-12)21(30-11-29)31-14-6-13(25)7-15(8-14)37-22(26,27)28/h3-8,18,35H,2,9-10H2,1H3,(H,30,31) PLBHGLHOEKBMEQ-UHFFFAOYSA-N 283186 Rac-N-[1-{N′-cyano-N-[3-fluoro-5-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 25 N-lysine methyltransferase SMYD2 Human 108 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283186&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397085 378164524 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540046 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(F)cc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(19(36)10-35)18-9-34(32-20(18)12-3-4-16(23)17(24)5-12)21(30-11-29)31-14-6-13(25)7-15(8-14)37-22(26,27)28/h3-8,18,35H,2,9-10H2,1H3,(H,30,31) PLBHGLHOEKBMEQ-UHFFFAOYSA-N 283187 N-[1-{N′-cyano-N-[3-fluoro-5-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 25.1::US10023539, Example 25.2 N-lysine methyltransferase SMYD2 Human 206 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283187&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397085 378164525 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540047 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(F)cc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H18Cl2F4N6O3/c1-2-33(19(36)10-35)18-9-34(32-20(18)12-3-4-16(23)17(24)5-12)21(30-11-29)31-14-6-13(25)7-15(8-14)37-22(26,27)28/h3-8,18,35H,2,9-10H2,1H3,(H,30,31) PLBHGLHOEKBMEQ-UHFFFAOYSA-N 283187 N-[1-{N′-cyano-N-[3-fluoro-5-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 25.1::US10023539, Example 25.2 N-lysine methyltransferase SMYD2 Human 10300 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283187&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397085 378164525 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540048 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(OC(F)(F)F)ccc1OC)=N/C#N)C(=O)CO InChI=1S/C23H21Cl2F3N6O4/c1-3-33(20(36)11-35)18-10-34(32-21(18)13-4-6-15(24)16(25)8-13)22(30-12-29)31-17-9-14(38-23(26,27)28)5-7-19(17)37-2/h4-9,18,35H,3,10-11H2,1-2H3,(H,30,31) SXYYEFNVOBRRSG-UHFFFAOYSA-N 283189 Rac-N-[1-{N′-cyano-N-[2-methoxy-5-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 26 N-lysine methyltransferase SMYD2 Human 30.6 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283189&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397075 378164526 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540049 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1CN1CCCC1)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C27H28Cl2F3N7O2/c1-2-38(24(41)15-40)23-14-39(36-25(23)17-6-8-20(28)21(29)11-17)26(34-16-33)35-22-12-19(27(30,31)32)7-5-18(22)13-37-9-3-4-10-37/h5-8,11-12,23,40H,2-4,9-10,13-15H2,1H3,(H,34,35) QSOXOTHDXTVRCQ-UHFFFAOYSA-N 283190 Rac-N-[1-{N′-cyano-N-[2-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]carbamimidoy}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 27 N-lysine methyltransferase SMYD2 Human 355 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283190&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397032 378164527 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540051 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1CN1CCCC1)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C27H28Cl2F3N7O2/c1-2-38(24(41)15-40)23-14-39(36-25(23)17-6-8-20(28)21(29)11-17)26(34-16-33)35-22-12-19(27(30,31)32)7-5-18(22)13-37-9-3-4-10-37/h5-8,11-12,23,40H,2-4,9-10,13-15H2,1H3,(H,34,35) QSOXOTHDXTVRCQ-UHFFFAOYSA-N 283191 N-[1-{N′-cyano-N-[2-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 27.1::US10023539, Example 27.2 N-lysine methyltransferase SMYD2 Human 73.2 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283191&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397032 378164528 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540052 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1CN1CCCC1)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C27H28Cl2F3N7O2/c1-2-38(24(41)15-40)23-14-39(36-25(23)17-6-8-20(28)21(29)11-17)26(34-16-33)35-22-12-19(27(30,31)32)7-5-18(22)13-37-9-3-4-10-37/h5-8,11-12,23,40H,2-4,9-10,13-15H2,1H3,(H,34,35) QSOXOTHDXTVRCQ-UHFFFAOYSA-N 283191 N-[1-{N′-cyano-N-[2-(pyrrolidin-1-ylmethyl)-5-(trifluoromethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide Isomer 1::US10023539, Example 27.1::US10023539, Example 27.2 N-lysine methyltransferase SMYD2 Human 1620 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283191&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397032 378164528 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540053 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OC(F)(F)F)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C23H18Cl2F6N6O3/c1-2-36(19(39)10-38)17-9-37(35-20(17)12-3-5-14(24)15(25)7-12)21(33-11-32)34-16-8-13(22(26,27)28)4-6-18(16)40-23(29,30)31/h3-8,17,38H,2,9-10H2,1H3,(H,33,34) DTCRUWDODVEYQC-UHFFFAOYSA-N 283193 Rac-N-[1-{N′-cyano-N-[2-(trifluoromethoxy)-5-(trifluoromethyl)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 28 N-lysine methyltransferase SMYD2 Human 140 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283193&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397080 378164529 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540054 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(OC(F)F)ccc1OCCCN(C)C)=N/C#N)C(=O)CO InChI=1S/C27H31Cl2F2N7O4/c1-4-37(24(40)15-39)22-14-38(35-25(22)17-6-8-19(28)20(29)12-17)27(33-16-32)34-21-13-18(42-26(30)31)7-9-23(21)41-11-5-10-36(2)3/h6-9,12-13,22,26,39H,4-5,10-11,14-15H2,1-3H3,(H,33,34) SGGNYLQLGPXEST-UHFFFAOYSA-N 283194 Rac-N-[1-(N′-cyano-N-{5-(difluoromethoxy)-2-[3-(dimethylamino)propoxy]phenyl}-carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 29 N-lysine methyltransferase SMYD2 Human 5.55 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283194&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397092 378164530 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540056 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OCCN1CCCC1)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C28H30Cl2F3N7O3/c1-2-39(25(42)16-41)23-15-40(37-26(23)18-5-7-20(29)21(30)13-18)27(35-17-34)36-22-14-19(28(31,32)33)6-8-24(22)43-12-11-38-9-3-4-10-38/h5-8,13-14,23,41H,2-4,9-12,15-16H2,1H3,(H,35,36) MQGRJGMZQQUXAA-UHFFFAOYSA-N 283195 Rac-N-[r-(N′-cyano-N-[2-[2-(pyrrolidin-1-yl)ethoxy]-5-(trifluormethyl)phenyl]carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 30 N-lysine methyltransferase SMYD2 Human 15.8 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283195&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397099 378164531 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540057 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OC1CCN(C)CC1)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C28H30Cl2F3N7O3/c1-3-39(25(42)15-41)23-14-40(37-26(23)17-4-6-20(29)21(30)12-17)27(35-16-34)36-22-13-18(28(31,32)33)5-7-24(22)43-19-8-10-38(2)11-9-19/h4-7,12-13,19,23,41H,3,8-11,14-15H2,1-2H3,(H,35,36) POSDRPCYJOVLGC-UHFFFAOYSA-N 283196 Rac-N-[1-(N′-cyano-N-{2-[(1-methylpiperidin-4-yl)oxy]-5-(trifluoromethyl)phenyl}-carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 31 N-lysine methyltransferase SMYD2 Human 9.09 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283196&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397060 378164532 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540059 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cc(ccc1OCCN1CCOCC1)C(F)(F)F)=N/C#N)C(=O)CO InChI=1S/C28H30Cl2F3N7O4/c1-2-39(25(42)16-41)23-15-40(37-26(23)18-3-5-20(29)21(30)13-18)27(35-17-34)36-22-14-19(28(31,32)33)4-6-24(22)44-12-9-38-7-10-43-11-8-38/h3-6,13-14,23,41H,2,7-12,15-16H2,1H3,(H,35,36) VFYQNZOVBXGWMV-UHFFFAOYSA-N 283197 Rac-N-[1-(N′-cyano-N-{2-[(1-methylpiperidin-4-yl)oxy]-5-(trifluoromethyl)phenyl}-carbamimidoyl)-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 32 N-lysine methyltransferase SMYD2 Human 26.1 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283197&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121405273 378164533 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540060 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C23H23ClF2N6O3/c1-3-31(20(34)12-33)19-11-32(30-21(19)15-7-8-18(24)14(2)9-15)23(28-13-27)29-16-5-4-6-17(10-16)35-22(25)26/h4-10,19,22,33H,3,11-12H2,1-2H3,(H,28,29) HRSYSGOOIRVSSD-UHFFFAOYSA-N 283198 Rac-N-[3-(4-chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]-carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 33 N-lysine methyltransferase SMYD2 Human 84.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283198&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397077 378164534 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540061 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C23H23ClF2N6O3/c1-3-31(20(34)12-33)19-11-32(30-21(19)15-7-8-18(24)14(2)9-15)23(28-13-27)29-16-5-4-6-17(10-16)35-22(25)26/h4-10,19,22,33H,3,11-12H2,1-2H3,(H,28,29) HRSYSGOOIRVSSD-UHFFFAOYSA-N 50180974 CHEMBL3818092::US10023539, Example 33.2 N-lysine methyltransferase SMYD2 Human 18400 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50180974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50180974&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397077 104065833 CHEMBL3818092 ZINC28566886 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540062 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C23H23ClF2N6O3/c1-3-31(20(34)12-33)19-11-32(30-21(19)15-7-8-18(24)14(2)9-15)23(28-13-27)29-16-5-4-6-17(10-16)35-22(25)26/h4-10,19,22,33H,3,11-12H2,1-2H3,(H,28,29) HRSYSGOOIRVSSD-UHFFFAOYSA-N 50180974 CHEMBL3818092::US10023539, Example 33.2 N-lysine methyltransferase SMYD2 Human 37.6 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50180974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50180974&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397077 104065833 CHEMBL3818092 ZINC28566886 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540064 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@H](C)N InChI=1S/C24H26ClF2N7O2/c1-4-33(22(35)15(3)29)20-12-34(32-21(20)16-8-9-19(25)14(2)10-16)24(30-13-28)31-17-6-5-7-18(11-17)36-23(26)27/h5-11,15,20,23H,4,12,29H2,1-3H3,(H,30,31)/t15-,20?/m0/s1 WTCKVJZPGHBPDT-OOJLDXBWSA-N 283201 N-[3-(4-chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-L-alaninamide Isomer 1::US10023539, Example 34.1::US10023539, Example 34.2 N-lysine methyltransferase SMYD2 Human 15400 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283201&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 132164974 378164537 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540065 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@H](C)N InChI=1S/C24H26ClF2N7O2/c1-4-33(22(35)15(3)29)20-12-34(32-21(20)16-8-9-19(25)14(2)10-16)24(30-13-28)31-17-6-5-7-18(11-17)36-23(26)27/h5-11,15,20,23H,4,12,29H2,1-3H3,(H,30,31)/t15-,20?/m0/s1 WTCKVJZPGHBPDT-OOJLDXBWSA-N 283201 N-[3-(4-chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-L-alaninamide Isomer 1::US10023539, Example 34.1::US10023539, Example 34.2 N-lysine methyltransferase SMYD2 Human 488 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283201&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 132164974 378164537 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540066 CCN(C1CN(N=C1c1ccc(Cl)c(F)c1)C(\Nc1cccc(OC(F)(F)F)c1)=N/C#N)C(=O)CO InChI=1S/C22H19ClF4N6O3/c1-2-32(19(35)11-34)18-10-33(31-20(18)13-6-7-16(23)17(24)8-13)21(29-12-28)30-14-4-3-5-15(9-14)36-22(25,26)27/h3-9,18,34H,2,10-11H2,1H3,(H,29,30) FOHOAFDRVOEKEW-UHFFFAOYSA-N 283203 Rac-N-[3-(4-chloro-3-fluorophenyl)-1-{N′-cyano-N-[3-(trifluoromethoxy)phenyl]-carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide::US10023539, Example 35 N-lysine methyltransferase SMYD2 Human 157 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283203&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397070 378164538 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540067 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CNC InChI=1S/C24H26ClF2N7O2/c1-4-33(21(35)12-29-3)20-13-34(32-22(20)16-8-9-19(25)15(2)10-16)24(30-14-28)31-17-6-5-7-18(11-17)36-23(26)27/h5-11,20,23,29H,4,12-13H2,1-3H3,(H,30,31) GYNCXGVLYCBEHV-UHFFFAOYSA-N 283204 US10023539, Example 36::rac-N-[3-(4-Chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-N2-methylglycinamide N-lysine methyltransferase SMYD2 Human 40.7 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283204&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121405274 378164539 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540069 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CNC InChI=1S/C24H26ClF2N7O2/c1-4-33(21(35)12-29-3)20-13-34(32-22(20)16-8-9-19(25)15(2)10-16)24(30-14-28)31-17-6-5-7-18(11-17)36-23(26)27/h5-11,20,23,29H,4,12-13H2,1-3H3,(H,30,31) GYNCXGVLYCBEHV-UHFFFAOYSA-N 283205 N-[3-(4-Chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-N2-methylglycinamide Isomer 2::US10023539, Example 36.1::US10023539, Example 36.2 N-lysine methyltransferase SMYD2 Human 754 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283205&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121405274 378164540 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540070 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)CNC InChI=1S/C24H26ClF2N7O2/c1-4-33(21(35)12-29-3)20-13-34(32-22(20)16-8-9-19(25)15(2)10-16)24(30-14-28)31-17-6-5-7-18(11-17)36-23(26)27/h5-11,20,23,29H,4,12-13H2,1-3H3,(H,30,31) GYNCXGVLYCBEHV-UHFFFAOYSA-N 283205 N-[3-(4-Chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-N2-methylglycinamide Isomer 2::US10023539, Example 36.1::US10023539, Example 36.2 N-lysine methyltransferase SMYD2 Human 22.9 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283205&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121405274 378164540 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540071 CCN(C1CN(N=C1c1ccc(Cl)c(C)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@@H](C)NC InChI=1S/C25H28ClF2N7O2/c1-5-34(23(36)16(3)30-4)21-13-35(33-22(21)17-9-10-20(26)15(2)11-17)25(31-14-29)32-18-7-6-8-19(12-18)37-24(27)28/h6-12,16,21,24,30H,5,13H2,1-4H3,(H,31,32)/t16-,21?/m1/s1 YLXKMPKVBVBGHR-UJONTBEJSA-N 283207 N-[3-(4-chloro-3-methylphenyl)-1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-N2-methyl-D-alaninamide::US10023539, Example 37 N-lysine methyltransferase SMYD2 Human 231 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283207&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397054 378164541 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540072 CC(C)[C@@](C)(N)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C24H25Cl2F2N7O2/c1-13(2)24(3,30)21(36)33-19-11-35(34-20(19)14-7-8-17(25)18(26)9-14)23(31-12-29)32-15-5-4-6-16(10-15)37-22(27)28/h4-10,13,19,22H,11,30H2,1-3H3,(H,31,32)(H,33,36)/t19?,24-/m1/s1 LOSHHNPLLHQJII-JKSFWZLDSA-N 283208 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-3-methyl-D-isovalinamide::US10023539, Example 38 N-lysine methyltransferase SMYD2 Human 32.0 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283208&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397045 378164542 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540074 CC(C)[C@@](C)(N)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C24H25Cl2F2N7O2/c1-13(2)24(3,30)21(36)33-19-11-35(34-20(19)14-7-8-17(25)18(26)9-14)23(31-12-29)32-15-5-4-6-16(10-15)37-22(27)28/h4-10,13,19,22H,11,30H2,1-3H3,(H,31,32)(H,33,36)/t19?,24-/m1/s1 LOSHHNPLLHQJII-JKSFWZLDSA-N 283209 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-3-methyl-D-isovalinamide Isomer 2::US10023539, Example 38.1::US10023539, Example 38.2 N-lysine methyltransferase SMYD2 Human 13500 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283209&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397045 378164543 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540075 CC(C)[C@@](C)(N)C(=O)NC1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N InChI=1S/C24H25Cl2F2N7O2/c1-13(2)24(3,30)21(36)33-19-11-35(34-20(19)14-7-8-17(25)18(26)9-14)23(31-12-29)32-15-5-4-6-16(10-15)37-22(27)28/h4-10,13,19,22H,11,30H2,1-3H3,(H,31,32)(H,33,36)/t19?,24-/m1/s1 LOSHHNPLLHQJII-JKSFWZLDSA-N 283209 N-[1-{N′-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-3-methyl-D-isovalinamide Isomer 2::US10023539, Example 38.1::US10023539, Example 38.2 N-lysine methyltransferase SMYD2 Human 37.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283209&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121397045 378164543 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540077 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1)=N/C#N)C(=O)[C@H](N)CC(C)C InChI=1S/C26H28Cl2F3N7O2/c1-4-37(24(39)21(33)10-15(2)3)22-13-38(36-23(22)16-8-9-19(27)20(28)11-16)25(34-14-32)35-17-6-5-7-18(12-17)40-26(29,30)31/h5-9,11-12,15,21-22H,4,10,13,33H2,1-3H3,(H,34,35)/t21-,22?/m1/s1 XZGFKTGNPPPJQF-ZMFCMNQTSA-N 283211 N-[1-{N′-cyano-N-[3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-D-leucinamide::US10023539, Example 39 N-lysine methyltransferase SMYD2 Human 2400 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283211&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 132164969 378164544 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540078 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)(F)F)c1F)=N/C#N)C(=O)[C@H](N)C(C)C InChI=1S/C25H25Cl2F4N7O2/c1-4-37(23(39)21(33)13(2)3)18-11-38(36-22(18)14-8-9-15(26)16(27)10-14)24(34-12-32)35-17-6-5-7-19(20(17)28)40-25(29,30)31/h5-10,13,18,21H,4,11,33H2,1-3H3,(H,34,35)/t18?,21-/m1/s1 SVXJIYWLQNXTCV-BDPMCISCSA-N 283213 N-[1-{N′-Cyano-N-[2-fluoro-3-(trifluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-D-valinamide::US10023539, Example 40 N-lysine methyltransferase SMYD2 Human 418 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283213&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 132165034 378164546 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4 540079 CCN(C1CN(N=C1c1ccc(Cl)c(Cl)c1)C(\Nc1cccc(OC(F)F)c1)=N/C#N)C(=O)[C@H](N)C(C)C InChI=1S/C25H27Cl2F2N7O2/c1-4-35(23(37)21(31)14(2)3)20-12-36(34-22(20)15-8-9-18(26)19(27)10-15)25(32-13-30)33-16-6-5-7-17(11-16)38-24(28)29/h5-11,14,20-21,24H,4,12,31H2,1-3H3,(H,32,33)/t20?,21-/m1/s1 WZLUBNDBNNVXDT-BPGUCPLFSA-N 283214 N-[1-{N′-Cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-3-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-4-yl]-N-ethyl-D-valinamide::US10023539, Example 41 N-lysine methyltransferase SMYD2 Human 73.5 9 US Patent 10.7270/Q2MG7RKD aid1795654 US10023539 Mowat, JS; Stellfeld, T; Stresemann, C; Hillig, R; Kohr, S; Stockigt, D; Weiske, J; Brumby, T; Barak, N; Christ, C; Ter Laak, A; Badock, V; Crampton, RH; Stefanuti, I 7/17/2018 1/6/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=283214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9633&target=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=283214&enzyme=N-lysine+methyltransferase+SMYD2&column=ki&startPg=0&Increment=50&submit=Search 121405335 378164547 1 MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH 3QWV,3QWW,3RIB,3TG4,3TG5,4WUY,4YND,5ARF,5ARG,5V3H N-lysine methyltransferase SMYD2 SMYD2_HUMAN Q9NRG4 B2R9P9 I6L9H7 Q4V765 Q5VSH9 Q96AI4